For weight management, NICE has approved: Semaglutide 2.4 mg (TA875) for adults with a BMI of 35 kg/m (or 32.5 kg/m for people from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean backgrounds) with at least one weight-related comorbidity, and for some people with BMI 30-34.9 kg/m meeting specific criteria
animalis ssp 420: -2.4% or -2.31cm reduction belly area & increase in short chain fatty acids
With a half-life of approximately 5 days, tirzepatide gradually clears from the system over 3-4 weeks after the final injection
The pentadecapeptide BPC-157 has been shown to have anti-inflammatory and wound-healing effects on multiple target tissues and organs
While some patients notice improved brightness and smoothness after one treatment, optimal results usually develop over a series of peels